Impact of type and severity of postoperative complications on long-term outcomes after colorectal liver metastases resection.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 02 02 2020
revised: 09 03 2020
accepted: 13 04 2020
pubmed: 27 4 2020
medline: 12 8 2020
entrez: 27 4 2020
Statut: ppublish

Résumé

Postoperative complications (POCs) after hepatic resection for colorectal liver metastases (CRLM) adversely affect long-term survival. The aim of this study was to analyze the effect of POC etiology and severity on overall survival (OS) and disease-free survival (DFS). A retrospective study of 254 consecutive hepatectomies for CRLM was performed. Univariate and multivariate analyses were performed to determine the effects of demographic, tumor-related and perioperative variables on OS and DFS. A 1:1 propensity score matching (PSM) was then used to compare patients with different POC etiology: infective (Inf-POC), noninfective (Non-inf POC), and no-complications (No-POC). Inf-POC, Non-inf POC, and No-POC patients represented 18.8%, 19.2%, and 62% of the sample, respectively. In univariate and multivariate analyses infectious POC were independent risk factors for decreased OS and DFS. After PSM, Inf-POC group presented decreased OS and DFS when compared with Non-inf POC (5-year OS 31.8% vs 51.6%; P = .05 and 5-year DFS 13.6% vs 31.9%; P = .04) and with No-POC (5-year OS 29.4% vs 58.7%; P = .03 and 5-year DFS 11.8% vs 39.7%; P = .03). There were no differences between Non-inf POC and No-POC patients. POC severity calculated using the Comprehensive Complications Index did not influence OS and DFS before and after PSM. The negative oncological impact of POCs after CRLM resection is determined by infective etiology not by severity.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Postoperative complications (POCs) after hepatic resection for colorectal liver metastases (CRLM) adversely affect long-term survival. The aim of this study was to analyze the effect of POC etiology and severity on overall survival (OS) and disease-free survival (DFS).
METHODS METHODS
A retrospective study of 254 consecutive hepatectomies for CRLM was performed. Univariate and multivariate analyses were performed to determine the effects of demographic, tumor-related and perioperative variables on OS and DFS. A 1:1 propensity score matching (PSM) was then used to compare patients with different POC etiology: infective (Inf-POC), noninfective (Non-inf POC), and no-complications (No-POC).
RESULTS RESULTS
Inf-POC, Non-inf POC, and No-POC patients represented 18.8%, 19.2%, and 62% of the sample, respectively. In univariate and multivariate analyses infectious POC were independent risk factors for decreased OS and DFS. After PSM, Inf-POC group presented decreased OS and DFS when compared with Non-inf POC (5-year OS 31.8% vs 51.6%; P = .05 and 5-year DFS 13.6% vs 31.9%; P = .04) and with No-POC (5-year OS 29.4% vs 58.7%; P = .03 and 5-year DFS 11.8% vs 39.7%; P = .03). There were no differences between Non-inf POC and No-POC patients. POC severity calculated using the Comprehensive Complications Index did not influence OS and DFS before and after PSM.
CONCLUSION CONCLUSIONS
The negative oncological impact of POCs after CRLM resection is determined by infective etiology not by severity.

Identifiants

pubmed: 32335938
doi: 10.1002/jso.25946
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-225

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Nathan H, Yin H, Wong SL. Postoperative complications and long-term survival after complex cancer resection. Ann Surg Oncol. 2017;24:638-644. https://doi.org/10.1245/s10434-016-5569-5
Law WL, Choi HK, Lee YM, Ho JW. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol. 2008;14:2559-2566. https://doi.org/10.1245/s10434-007-9434-4
Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253:890-899. https://doi.org/10.1097/SLA.0b013e3182128929
Slankamenac K, Slankamenac M, Schlegel A, et al. Impact of postoperative complications on readmission and long-term survival in patients following surgery for colorectal cancer. Int J Colorectal Dis. 2017;32:805-811. https://doi.org/10.1007/s00384-017-2811-y
Matsuda A, Matsumoto S, Seya T, et al. Does postoperative complication have a negative impact on long-term outcomes following hepatic resection for colorectal liver metastasis?: a metaanalysis. Ann Surg Oncol. 2013;20:2485-2492. https://doi.org/10.1245/s10434-013-2972-z
Lodewick TM, deJong MC, vanDam RM, et al. Effects of postoperative morbidity on long-term outcome following surgery for colorectal liver metastases. World J Surg. 2015;39:478-486. https://doi.org/10.1007/s00268-014-2799-1
Ito H, Are C, Gonen M, et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247:994-1002. https://doi.org/10.1097/SLA.0b013e31816c405f
Dorcaratto D, Mazzinari G, Fernandez M, et al. Impact of postoperative complications on survival and recurrence after resection of colorectal liver metastases: systematic review and meta-analysis. Ann Surg. 2019;270:1018-1027. https://doi.org/10.1097/SLA.0000000000003254
Yamashita S, Sheth RA, Niekamp AS, et al. Comprehensive complication index predicts cancer-specific survival after resection of colorectal metastases independent of RAS mutational status. Ann Surg. 2017;266:1045-1054. https://doi.org/10.1097/SLA.0000000000002018
Memeo R, deBlasi V, Adam R, et al. Postoperative complications impact long-term survival in patients who underwent hepatectomies for colorectal liver metastases: a propensity score matching analysis. J Gastrointest Surg. 2018;22:2045-2054. https://doi.org/10.1007/s11605-018-3854-2
Cheng A, Kessler D, Mackinnon R, et al. Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements. Simul Healthc. 2016;11:238-248. https://doi.org/10.1097/SIH.0000000000000150
Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258:1-7. https://doi.org/10.1097/SLA.0b013e318296c732
Clavien PA, Barkun J, deOliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
Slankamenac K, Nederlof N, Pessaux P, et al. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014;260:757-763. https://doi.org/10.1097/SLA.0000000000000948
Buettner S, Ethun CG, Poultsides G, et al. Surgical site infection is associated with tumor recurrence in patients with extrahepatic biliary malignancies. J Gastrointest Surg. 2017;21:1813-1820. https://doi.org/10.1007/s11605-017-3571-2
Artinyan A, Nunoo-Mensah JW, Balasubramaniam S, et al. Prolonged postoperative ileus: definition, risk factors and predictors after surgery. World J Surg. 2008;32(1495-1500):1495-1500. https://doi.org/10.1007/s00268-008-9491-2
Adam R, deGramont A, Figueras J, et al. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41:729-741. https://doi.org/10.1016/j.ctrv.2015.06.006
Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol. 2007;14:3481-3491. https://doi.org/10.1245/s10434-007-9522-5
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Colon cancer Version 2.2019. 2019; National Comprehensive Cancer Network.
Yoshino T, Arnold D, Taniguchi H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol. 2018;29:44-70. https://doi.org/10.1093/annonc/mdx738
Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26:734-753. https://doi.org/10.1002/sim.2580
Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, et al. Impact of surgical margin width on recurrence and overall survival following r0 hepatic resection of colorectal metastases: a systematic review and meta-analysis. Ann Surg. 2018;267:1047-1055. https://doi.org/10.1097/SLA.0000000000002552
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet Oncol. 2008;371:1007-1016. https://doi.org/10.1016/S1470-2045(13)70447-9
Vallance AE, vanderMeulen J, Kuryba A, et al. Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases. Br J Surg. 2017;104:918-925. https://doi.org/10.1002/bjs.10501
Dunne DFJ, Jack S, Jones RP, et al. Randomized clinical trial of prehabilitation before planned liver resection. Br J Surg. 2016;103:504-512. https://doi.org/10.1002/bjs.10096
Salvans S, Mayol X, Alonso S, et al. Postoperative peritoneal infection enhances migration and invasion capacities of tumor cells in vitro: an insight into the association between anastomotic leak and recurrence after surgery for colorectal cancer. Ann Surg. 2014;260:939-943. https://doi.org/10.1097/SLA.0000000000000958
Merkow RP, Bilimoria KY, Tomlinson JS, et al. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Ann Surg. 2014;260:372-377. https://doi.org/10.1097/SLA.0000000000000378
Kim IY, Kim BR, Kim YW. Factors affecting use and delay (≥ 8 weeks) of adjuvant chemotherapy after colorectal cancer surgery and the impact of chemotherapy-use and delay on oncologic outcomes. PLoS One. 2015;10:e0138720. https://doi.org/10.1371/journal.pone.0138720
Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013;4:114. https://doi.org/10.3389/fimmu.2013.00114
Medler TR, Cotechini T, Coussens LM. Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance. Trends Cancer. 2015;1:66-75. https://doi.org/10.1016/j.trecan.2015.07.008
Peng PD, vanVledder MG, Tsai S, et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB. 2011;13:439-446. https://doi.org/10.1111/j.1477-2574.2011.00301
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318. https://doi.org/10.1097/00000658-199909000-00004
Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer. 1996;77:1254-1262.
Farid SG, Aldouri A, Morris-Stiff G, et al. Correlation between postoperative infectious complications and long-term outcomes after hepatic resection for colorectal liver metastases. Ann Surg. 2010;251:91-100. https://doi.org/10.1097/SLA.0b013e3181bfda3c
Mavros MN, deJong M, Dogeas E, Hyder O, Pawlik TM. Impact of complications on long-term survival after resection of colorectal liver metastases. Br J Surg. 2013;100:711-718. https://doi.org/10.1002/bjs.9060
Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246:806-814. https://doi.org/10.1097/SLA.0b013e318142d964

Auteurs

María-Carmen Fernández-Moreno (MC)

Department of Surgery, Liver, Biliary, and Pancreatic Unit, Biomedical Research Institute INCLIVA, Hospital Clínico University of Valencia, Valencia, Spain.

Dimitri Dorcaratto (D)

Department of Surgery, Liver, Biliary, and Pancreatic Unit, Biomedical Research Institute INCLIVA, Hospital Clínico University of Valencia, Valencia, Spain.

Marina Garcés-Albir (M)

Department of Surgery, Liver, Biliary, and Pancreatic Unit, Biomedical Research Institute INCLIVA, Hospital Clínico University of Valencia, Valencia, Spain.

Elena Muñoz (E)

Department of Surgery, Liver, Biliary, and Pancreatic Unit, Biomedical Research Institute INCLIVA, Hospital Clínico University of Valencia, Valencia, Spain.

Ricardo Arvizu (R)

Department of Surgery, Liver, Biliary, and Pancreatic Unit, Biomedical Research Institute INCLIVA, Hospital Clínico University of Valencia, Valencia, Spain.

Joaquín Ortega (J)

Department of Surgery, Liver, Biliary, and Pancreatic Unit, Biomedical Research Institute INCLIVA, Hospital Clínico University of Valencia, Valencia, Spain.

Luis Sabater (L)

Department of Surgery, Liver, Biliary, and Pancreatic Unit, Biomedical Research Institute INCLIVA, Hospital Clínico University of Valencia, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH